Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Titel:
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Auteur:
Buzdar, A.U. Xu, B. Digumarti, R. Goedhals, L. Hu, X. Semiglazov, V. Cheporov, S. Gotovkin, E. Hoersch, S. Rittweger, K. Miles, D.W. O’Shaughnessy, J. Tjulandin, S.